The veterinary vaccines market is projected to reach US$ 15,536.38 million by 2028 from US$ 9,984.65 million in 2021; it is estimated to register a CAGR of 6.5% from 2021 to 2028.
Veterinary vaccines are parenteral products used to prevent infectious diseases caused by various pathogens. These vaccines protect animals from a variety of life-threatening diseases. Veterinary vaccines serve a critical role in ensuring the longevity, good health, and overall production of pets and livestock cost-effectively. The veterinary vaccines are classified as inactivated, live-attenuated, toxoid, and recombinant vaccines.
According to WHO, foodborne disease (FBD) is one of the primary causes of morbidity and mortality globally, affecting a third of the world's population each year. The diseases can be developed by several chemical pollutants, bacteria, viruses, parasites, and biotoxins, and are generally referred to as neglected diseases. The spread of FBD and its repercussions are major concerns to human health. The expanding human population and changing diet trends (more protein in meals) are expected to boost the consumption of animal products to 376 million tons by 2030. The growing demand for animal products, coupled with increasing awareness about animal welfare, leads to changes in operational management.
Like humans, pets and farm animals are susceptible to many diseases caused by bacteria, viruses, fungus, and parasites. Therefore, several techniques, such as veterinary vaccination, have been employed. The vaccines are licensed and manufactured under tight regulatory circumstances to ensure their safety, effectiveness, and quality. Veterinary vaccines against foodborne parasites improve animal health by reducing animal infections and help improve public health by managing an essential source of FBDs. In addition, vaccines safeguard farm animals by preventing or reducing the danger of certain infectious diseases.
Healthy animals are the cornerstone of healthy eating; hence, immunizations help safeguard animal-made foods. The veterinary profession provides farmers with the immunizations needed to protect their animals' health and welfare.
In animal husbandry, using antibiotics only when essential to protect animal health means depending on non-antibiotic alternatives to control animal health and making optimal treatment decisions regarding the antibiotic selection and treatment procedure when antibiotics are required. Vaccines are a possible alternative to intensive antibiotics. In a recent cross-border expert rating of alternatives to antimicrobial drugs in pig production, vaccinations were ranked in terms of perceived feasibility and among the top five alternative techniques in terms of perceived efficacy.
The global veterinary vaccines market, based on vaccine type, is segmented into livestock vaccines, companion animal vaccines, and others. The livestock vaccines segment is likely to hold the largest market share in 2021. However, the companion animal segment is anticipated to register the highest CAGR of 7.0% during the forecast period.
The global veterinary vaccines market, based on technology, is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and others. In 2021, the live attenuated vaccines segment is likely to hold the largest market share. However, the inactivated vaccines segment is expected to grow at the highest CAGR from 2021 to 2028.
National Institutes of Health (NIH), National Healthcare Service (NHS), Centers for Disease Control and Prevention (CDC), National Chronic Kidney Disease, National Center for Biotechnology Information, National Statistics Institute, and World Health Organization (WHO) are a few of the major secondary sources referred to while preparing the report on the veterinary vaccines market.
Reasons to Buy
Veterinary vaccines are parenteral products used to prevent infectious diseases caused by various pathogens. These vaccines protect animals from a variety of life-threatening diseases. Veterinary vaccines serve a critical role in ensuring the longevity, good health, and overall production of pets and livestock cost-effectively. The veterinary vaccines are classified as inactivated, live-attenuated, toxoid, and recombinant vaccines.
According to WHO, foodborne disease (FBD) is one of the primary causes of morbidity and mortality globally, affecting a third of the world's population each year. The diseases can be developed by several chemical pollutants, bacteria, viruses, parasites, and biotoxins, and are generally referred to as neglected diseases. The spread of FBD and its repercussions are major concerns to human health. The expanding human population and changing diet trends (more protein in meals) are expected to boost the consumption of animal products to 376 million tons by 2030. The growing demand for animal products, coupled with increasing awareness about animal welfare, leads to changes in operational management.
Like humans, pets and farm animals are susceptible to many diseases caused by bacteria, viruses, fungus, and parasites. Therefore, several techniques, such as veterinary vaccination, have been employed. The vaccines are licensed and manufactured under tight regulatory circumstances to ensure their safety, effectiveness, and quality. Veterinary vaccines against foodborne parasites improve animal health by reducing animal infections and help improve public health by managing an essential source of FBDs. In addition, vaccines safeguard farm animals by preventing or reducing the danger of certain infectious diseases.
Healthy animals are the cornerstone of healthy eating; hence, immunizations help safeguard animal-made foods. The veterinary profession provides farmers with the immunizations needed to protect their animals' health and welfare.
In animal husbandry, using antibiotics only when essential to protect animal health means depending on non-antibiotic alternatives to control animal health and making optimal treatment decisions regarding the antibiotic selection and treatment procedure when antibiotics are required. Vaccines are a possible alternative to intensive antibiotics. In a recent cross-border expert rating of alternatives to antimicrobial drugs in pig production, vaccinations were ranked in terms of perceived feasibility and among the top five alternative techniques in terms of perceived efficacy.
The global veterinary vaccines market, based on vaccine type, is segmented into livestock vaccines, companion animal vaccines, and others. The livestock vaccines segment is likely to hold the largest market share in 2021. However, the companion animal segment is anticipated to register the highest CAGR of 7.0% during the forecast period.
The global veterinary vaccines market, based on technology, is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and others. In 2021, the live attenuated vaccines segment is likely to hold the largest market share. However, the inactivated vaccines segment is expected to grow at the highest CAGR from 2021 to 2028.
National Institutes of Health (NIH), National Healthcare Service (NHS), Centers for Disease Control and Prevention (CDC), National Chronic Kidney Disease, National Center for Biotechnology Information, National Statistics Institute, and World Health Organization (WHO) are a few of the major secondary sources referred to while preparing the report on the veterinary vaccines market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Veterinary Vaccines market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global Veterinary Vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Veterinary Vaccines Market - By Vaccine Type
1.3.2 Global Veterinary Vaccines Market - By Technology
1.3.3 Global Veterinary Vaccines Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Veterinary Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Veterinary Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Zoonotic Diseases
5.1.2 Rising Prevalence of Foodborne Diseases and Infections
5.2 Market Restraints
5.2.1 Strict Government Rules Related to Usage of Veterinary Vaccines
5.3 Market Opportunities
5.3.1 Growing Market in Untapped Economies
5.4 Future Trends
5.4.1 Rising Awareness Related to Diagnosis and Treatment of Infectious Diseases
5.5 Impact Analysis
6. Veterinary Vaccines Market- Global Analysis
6.1 Global Veterinary Vaccines Market Revenue Forecast and Analysis
6.2 Global Veterinary Vaccines Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Veterinary Vaccines Market Revenue and Forecasts To 2028- By Vaccine Type
7.1 Overview
7.2 Global Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
7.3 Livestock Vaccines
7.3.1 Overview
7.3.2 Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Bovine Vaccines
7.3.3.1 Overview
7.3.3.2 Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Small Ruminant Vaccines
7.3.4.1 Overview
7.3.4.2 Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Companion Vaccines
7.4.1 Overview
7.4.2 Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Feline Vaccines
7.4.3.1 Overview
7.4.3.2 Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 Canine Vaccines
7.4.4.1 Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 Other Companion Animal Vaccines
7.4.5.1 Overview
7.4.5.2 Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
8. Veterinary Vaccines Market Revenue and Forecasts To 2028 - Technology
8.1 Overview
8.2 Global Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.4 Inactivated Vaccines
8.4.1 Overview
8.4.2 Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.5 Toxoid Vaccines
8.5.1 Overview
8.5.2 Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.6 Recombinant Vaccines
8.6.1 Overview
8.6.2 Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
9. Veterinary Vaccines Market Revenue and Forecasts to 2028 - Geographical Analysis
9.1 North America: Veterinary Vaccines Market
9.1.1 Overview
9.1.2 North America: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Veterinary Vaccines Market, Vaccine Type, 2019-2028 (US$ Million)
9.1.3.1 North America: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.1.3.2 North America: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.1.4 North America: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.1.5 North America: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 US: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 US: Veterinary Vaccines Market, Vaccine Type, 2019-2028 (US$ Million)
9.1.5.1.2.1 US: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.1.5.1.2.2 US: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019-2028 (US$ Million)
9.1.5.1.3 US: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.1.5.2 Canada: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Canada: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 Canada: Veterinary Vaccines Market, Vaccine Type, 2019-2028 (US$ Million)
9.1.5.2.2.1 Canada: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.1.5.2.2.2 Canada: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019-2028 (US$ Million)
9.1.5.2.3 Canada: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.1.5.3 Mexico: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Mexico: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 Mexico: Veterinary Vaccines Market, Vaccine Type, 2019-2028 (US$ Million)
9.1.5.3.2.1 Mexico: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.1.5.3.2.2 Mexico: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019-2028 (US$ Million)
9.1.5.3.3 Mexico: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.2 Europe: Veterinary Vaccines Market Revenue and Forecasts to 2028
9.2.1 Overview
9.2.2 Europe: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.3 Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type(US$ Mn)
9.2.3.1 Europe: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.2.3.2 Europe: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.2.4 Europe: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.2.5 Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)
9.2.5.1 Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5.1.1 Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5.1.2 Germany Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type(US$ Mn)
9.2.5.1.2.1 Germany: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.2.5.1.2.2 Germany: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.2.5.1.3 Germany: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.2.5.2 France Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
9.2.5.2.1 France: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.2 France Veterinary Vaccines : Market, By Vaccine Type, 2019-2028 (US$ Million)
9.2.5.2.2.1 France: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.2.5.2.2.2 France: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.2.5.2.3 France: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.2.5.3 UK: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 UK: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.2 UK: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.2.5.3.2.1 UK: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.2.5.3.2.2 UK: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.2.5.3.3 UK: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.2.5.4 Italy: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Italy: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.2 Italy: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.2.5.4.2.1 Italy: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.2.5.4.2.2 Italy: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.2.5.4.3 Italy: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.2.5.5 Spain: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Spain: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.2 Spain: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.2.5.5.2.1 Spain: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.2.5.5.2.2 Spain: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.2.5.5.3 Spain: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.2.5.6 Rest of Europe: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Rest of Europe: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.2 Rest of Europe: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.2.5.6.2.1 Rest of Europe: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.2.5.6.2.2 Rest of Europe: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.3 Asia Pacific: Veterinary Vaccines Market
9.3.1 Overview
9.3.2 Asia Pacific: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia Pacific: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.3.3.1 Asia Pacific: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.3.3.2 Asia Pacific: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.3.4 Asia Pacific: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.3.5 Asia Pacific: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2 China: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.1 China: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.3.5.2.1.1 China: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.3.5.2.1.2 China: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.3.5.2.2 China: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.3.5.3 Japan: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.1 Japan: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.2 Japan: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.3.5.3.2.1 Japan: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.3.5.3.2.2 Japan: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.3.5.3.3 Japan: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.3.5.4 India: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 India: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.2 India: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.3.5.4.2.1 India: Veterinary Vaccines Market, By Livestock Vaccines, 2019-2028 (US$ Million)
9.3.5.4.2.2 India: Veterinary Vaccines Market, By Companion Vaccines, 2019-2028 (US$ Million)
9.3.5.4.3 India: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.3.5.5 Australia: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Australia: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.2 Australia: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.3.5.5.2.1 Australia: Veterinary Vaccines Market, By Livestock Vaccines, 2019-2028 (US$ Million)
9.3.5.5.2.2 Australia: Veterinary Vaccines Market, By Companion Vaccines, 2019-2028 (US$ Million)
9.3.5.5.3 Australia: Veterinary Vaccines Market, by Technology , 2019-2028 (US$ Million)
9.3.5.6 South Korea: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 South Korea: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.2 South Korea: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.3.5.6.2.1 South Korea: Veterinary Vaccines Market, By Livestock Vaccines, 2019-2028 (US$ Million)
9.3.5.6.2.2 South Korea: Veterinary Vaccines Market, By Companion Vaccines, 2019-2028 (US$ Million)
9.3.5.6.3 South Korea: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.3.5.7 Rest of Asia Pacific: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.7.1 Rest of Asia Pacific: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.7.2 Rest of Asia Pacific: Veterinary Vaccines Market, By Vaccine Type, 2019-2028 (US$ Million)
9.3.5.7.2.1 Rest of Asia Pacific: Veterinary Vaccines Market, By Livestock Vaccines, 2019-2028 (US$ Million)
9.3.5.7.2.2 Rest of Asia Pacific: Veterinary Vaccines Market, By Companion Vaccines, 2019-2028 (US$ Million)
9.3.5.7.3 Rest of Asia Pacific: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.4 Middle East and Africa: Veterinary Vaccines Market
9.4.1 Overview
9.4.2 Middle East & Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa Veterinary Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
9.4.3.1 Middle East & Africa Veterinary Vaccines Market, by Livestock Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.3.2 Middle East & Africa Veterinary Vaccines Market, by Companion Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.4 Middle East & Africa: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.4.5 Middle East & Africa: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.4.5.1 Saudi Arabia: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.1 Saudi Arabia: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.2 Saudi Arabia Veterinary Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.2.1 Saudi Arabia Veterinary Vaccines Market, by Livestock Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.2.2 Saudi Arabia Veterinary Vaccines Market, by Companion Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.3 Saudi Arabia: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.4.5.2 UAE: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.1 UAE: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.2 UAE Veterinary Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.2.1 UAE Veterinary Vaccines Market, by Livestock Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.2.2 UAE Veterinary Vaccines Market, by Companion Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.3 UAE: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.4.5.3 South Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.1 South Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.2 South Africa Veterinary Vaccines Market, by Vaccine Type- Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.2.1 South Africa Veterinary Vaccines Market, by Livestock Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.2.2 South Africa Veterinary Vaccines Market, by Companion Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.3 South Africa: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.4.5.4 Rest of Middle East and Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.1 Rest of Middle East and Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.2 Rest of Middle East & Africa Veterinary Vaccines Market, by Vaccines Type- Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.2.1 Rest of Middle East & Africa Veterinary Vaccines Market, by Livestock Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.2.2 Rest of Middle East & Africa Veterinary Vaccines Market, by Companion Vaccines- Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.3 Rest of Middle East & Africa: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.5 South And Central America Veterinary Vaccines Market Revenue and Forecasts To 2028
9.5.1 Overview
9.5.2 South and Central America Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.3 South and Central America: Veterinary Vaccines Market, Vaccine Type, 2019-2028 (US$ Million)
9.5.3.1 South and Central America: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.5.3.2 South and Central America: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.5.4 South and Central America: Veterinary Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.5.5 South and Central America Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)
9.5.5.1 Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.1.1 Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.1.2 Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
9.5.5.1.2.1 Brazil: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.5.5.1.2.2 Brazil: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.5.5.1.3 Brazil: Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
9.5.5.2 Argentina Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.2.1 Argentina Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.2.2 Argentina: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
9.5.5.2.2.1 Argentina: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.5.5.2.2.2 Argentina: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.5.5.2.3 Argentina: Veterinary Vaccines Market Revenue and Forecasts To 2028, By Technology (US$ Million)
9.5.5.3 Rest of South and Central America: Veterinary Vaccines Market- Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.1 Rest of South and Central America: Veterinary Vaccines Market- Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.2 Rest of South & Central America: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
9.5.5.3.2.1 Rest of South & Central America: Veterinary Vaccines Market, by Livestock Vaccines, 2019-2028 (US$ Million)
9.5.5.3.2.2 Rest of South & Central America: Veterinary Vaccines Market, by Companion Vaccines, 2019-2028 (US$ Million)
9.5.5.3.3 Rest of South & Central America: Veterinary Vaccines Market Revenue and Forecasts To 2028, By Technology (US$ Million)
10. Impact of COVID-19 Pandemic on Global Veterinary Vaccines Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Veterinary Vaccines Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Zoetis Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Virbac
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BIOVAC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NEOGEN Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Elanco
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 HIPRA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ceva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Hester Biosciences Limited
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Publisher
13.2 Glossary of Terms
List of Tables
Table 1. North America Veterinary Vaccines Market, Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Veterinary Vaccines Market, Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Veterinary Vaccines Market, by Companion Animal Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 8. US Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Veterinary Vaccines Market, Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Veterinary Vaccines Market, by Companion Animal Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Veterinary Vaccines Market, Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico: Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: Veterinary Vaccines Market, by Companion Animal Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Mn).
Table 18. Europe Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type(US$ Mn)
Table 22. Germany Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 25. France: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. France Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 27. France Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 28. France Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 29. UK: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 30. UK Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 31. UK: Veterinary Vaccines Market, By Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Veterinary Vaccines Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 49. China: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 50. China Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 51. China Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 52. China Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 53. Japan: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 58. India: Veterinary Vaccines Market, By Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 59. India: Veterinary Vaccines Market, By Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 60. India Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 61. Australia: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 62. Australia: Veterinary Vaccines Market, By Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 63. Australia: Veterinary Vaccines Market, By Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 65. South Korea: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 66. South Korea: Veterinary Vaccines Market, By Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 67. South Korea: Veterinary Vaccines Market, By Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 68. South Korea Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Asia Pacific: Veterinary Vaccines Market, By Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Asia Pacific: Veterinary Vaccines Market, By Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific: Veterinary Vaccines Market, By Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 73. Middle East & Africa Veterinary Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 74. Middle East & Africa Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East & Africa Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East & Africa Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 77. Saudi Arabia Veterinary Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 78. Saudi Arabia Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 79. Saudi Arabia Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 80. Saudi Arabia Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 81. UAE Veterinary Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 82. UAE Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 83. UAE Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 84. UAE Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 85. South Africa Veterinary Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 86. South Africa Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 87. South Africa Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Middle East & Africa Veterinary Vaccines Market, by Vaccines Type - Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East & Africa Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East & Africa Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East & Africa Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 93. South and Central America: Vaccines Market, Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America: Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America: Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America: Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 97. Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
Table 98. Brazil: Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil: Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil: Veterinary Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 101. Argentina: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
Table 102. Argentina: Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina: Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina: Veterinary Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 105. Rest of South & Central America: Veterinary Vaccines Market Revenue and Forecasts to 2028, Vaccine Type (US$ Million)
Table 106. Rest of South & Central America: Veterinary Vaccines Market, by Livestock Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South & Central America: Veterinary Vaccines Market, by Companion Vaccines - Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South & Central America: Veterinary Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms, Veterinary Vaccines MarketList of Figures
Figure 1. Veterinary Vaccines Market Segmentation
Figure 2. Veterinary Vaccines Market, By Region
Figure 3. Global Veterinary Vaccines Market Overview
Figure 4. Livestock Vaccines Segment Held Largest Share of Vaccine Type Segment in Veterinary Vaccines Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Veterinary Vaccines Market, by Geography (US$ Million)
Figure 7. Global Veterinary Vaccines Market- Leading Country Markets (US$ Million)
Figure 8. Global Veterinary Vaccines Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints Pertaining to Veterinary Vaccines Market
Figure 16. Global Veterinary Vaccines Market– Revenue Forecast and Analysis – 2021 – 2028
Figure 17. Global Veterinary Vaccines Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Veterinary Vaccines Market
Figure 19. Global Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
Figure 20. Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Global Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
Figure 29. Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Others: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. North America: Veterinary Vaccines Market, by Key Country – Revenue (2021) (US$ Million)
Figure 35. North America Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 37. US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Europe: Veterinary Vaccines Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 41. Europe: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)
Figure 43. Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 44. France: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. UK: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Italy: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Spain: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Rest of Europe: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Asia Pacific: Veterinary Vaccines Market, by Key Country – Revenue (2021) (US$ Million)
Figure 50. Asia Pacific Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 51. Asia Pacific: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 52. China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Rest of Asia Pacific: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Middle East & Africa: Veterinary Vaccines Market, by Key Country – Revenue (2021) (US$ Million)
Figure 59. Middle East & Africa Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. Middle East & Africa: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 61. Saudi Arabia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. UAE: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Africa: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of Middle East and Africa: Veterinary Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 65. South and Central America Veterinary Vaccines Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 66. South and Central America Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. South and Central America Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)
Figure 68. Brazil: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 69. Argentina Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 70. Rest of South and Central America: Veterinary Vaccines Market– Revenue and Forecast to 2028 (USD Mn)
Figure 71. Impact of COVID-19 Pandemic in North American Country Markets
Figure 72. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 74. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 75. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 76. Growth Strategies Done by the Companies in the Market (%)
Companies Mentioned
- Boehringer Ingelheim International GmbH
- MERCK
- Zoetis Services LLC
- Elanco
- Vetoquinol
- Ceva
- Virbac
- NEOGEN Corporation
- Biovac
- ImmuCell Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 181 |
| Published | December 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 9984.65 million |
| Forecasted Market Value ( USD | $ 15536.38 million |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
